SUBSCRIBE
SUBSCRIBE

AstraZeneca Pharmaceuticals LP

NEWS
Business
George Scangos’ Bold Vision
The former Biogen CEO is making waves at his new venture, Vir Biotechnology.
October 23, 2017
 · 
1 min read
 · 
Karl Thiel
Business
Scott Gottlieb’s Meteoric Rise?
A look at FDA head Scott Gottlieb’s career so far.
October 23, 2017
 · 
1 min read
 · 
Karl Thiel
Deals
Week in Review: WuXi AppTec Acquires US-Global Clinical CRO
WuXi AppTec, a China CRO/CMO, will acquire ResearchPoint Global, of Texas, a global clinical-stage contract research company, to extend the reach of its own clinical CRO coverage.
October 23, 2017
 · 
1 min read
AstraZeneca Gets in on ADC Therapeutics’ Mega $200M Funding Round
ADC Therapeutics announced it had raised $200M through an oversubscribed private placement.
October 23, 2017
 · 
3 min read
 · 
Mark Terry
Business
AstraZeneca Inks R&D Deal With Ramaswamy’s Roivant for Hush-Hush Indication
Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra.
October 19, 2017
 · 
3 min read
 · 
Mark Terry
Sotera Employees Misappropriated Masimo Trade Secr
Policy
Big Pharma Allegedly Funded Anti-U.S. Militia in Iraq
The lawsuit was filed on behalf of members of the American military who were injured or killed by attacks between 2005 and 2009
October 18, 2017
 · 
1 min read
Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission
Business
Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission
October 11, 2017
 · 
3 min read
Business
AstraZeneca PLC May Move Some Manufacturing, R&D Out Of The UK Due To Brexit
October 4, 2017
 · 
1 min read
Deals
Why AstraZeneca PLC’s ‘Big Pipeline’ Makes It A Possible Take-Out Candidate
September 22, 2017
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Cellectis Announces 2026 Strategy and Catalysts
January 9, 2026
 · 
7 min read
Press Releases
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
January 8, 2026
 · 
2 min read
Press Releases
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
January 6, 2026
 · 
2 min read
Press Releases
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
December 30, 2025
 · 
5 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer
December 23, 2025
 · 
19 min read
Press Releases
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer
December 23, 2025
 · 
20 min read
Press Releases
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer
December 23, 2025
 · 
19 min read
Press Releases
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
December 19, 2025
 · 
2 min read
Press Releases
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy
December 18, 2025
 · 
9 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
December 16, 2025
 · 
19 min read
Load More